Corcept Therapeutics Incorporated
CORT
$71.38
$0.921.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 133.99M | 141.21M | 141.82M | 125.98M | 118.02M |
| Total Depreciation and Amortization | 1.62M | 1.34M | 1.15M | 938.00K | 1.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.43M | 10.23M | 5.68M | 8.91M | 10.64M |
| Change in Net Operating Assets | 30.40M | 45.30M | -3.99M | -12.10M | -5.50M |
| Cash from Operations | 179.44M | 198.07M | 144.65M | 123.73M | 124.84M |
| Capital Expenditure | -2.28M | -2.17M | -2.05M | -453.00K | -139.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -169.49M | -175.43M | -94.10M | -161.23M | -125.44M |
| Cash from Investing | -171.76M | -177.60M | -96.15M | -161.68M | -125.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.38M | 9.62M | 8.96M | 7.83M | 6.09M |
| Repurchase of Common Stock | -78.99M | -37.97M | -31.98M | -13.67M | -155.54M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.61M | -28.35M | -23.02M | -5.84M | -149.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.93M | -7.89M | 25.49M | -43.79M | -150.19M |